Definitive Contract 75A50122C00035
- Not listed
- The Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute awarded a $250,000 firm fixed price purchase order to Arete Biosciences, LLC of Chicago, Illinois. The contract is to support the Rapid Acceleration of Diagnostics (RADX) Program Technology effort through January 18, 2022. No major subcontractors or set aside designations were indicated. The award provides funding for Arete Biosciences to likely deliver diagnostic technologies or...
- <p>This is a $299,961.00 SBIR Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Cubit Diagnostics, Inc. (doing business as Arete Biosciences) for the development of an ultrasensitive, rapid, and easy-to-use at-home molecular test for Hepatitis C, Hepatitis B, and HIV. The contract has a firm fixed price and a completion date of April 30, 2025. It is designated as a Total Small Business set-aside contract.</p>
- This definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Luminex Corporation is valued at $642,450.00. The contract supports the development of Luminex's ARIES SARS-CoV-2 assay under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002. Special Instructions 019 revised the description for mitigating long-term effects of respiratory distress and updated submission deadlines...
- This definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Orasure Technologies Inc. is valued at $710,310 to support the development of a rapid antigen test for COVID-19. The contract was awarded under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002 and will deliver research and development efforts towards a host-directed therapeutic to aid long-term outcomes from lung...
- This is a $354,267.22 firm fixed price definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Grip Molecular Technologies Inc., a small disadvantaged business. The contract involves research and development of ultra-sensitive photonic integrated circuit detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza A antigens using graphene biosensors. The goal is to support the...
- This is a $9,850,000.00 firm fixed price purchase order awarded by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to Luminex Corporation. The contract is to expand the use of Luminex's ARIES SARS-CoV-2 assay, which is a molecular diagnostic test for COVID-19. This award was not set aside for any specific business type. Luminex is a manufacturer of biological testing technologies, including multiplex diagnostic solutions,...
- This $699,000 firm fixed price contract was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Hologic, Inc. to develop a molecular diagnostic test to detect SARS-CoV-2 using the Hologic Panther Fusion system. The test will be developed under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002, which sought host-directed therapeutic candidates to aid long-term outcomes from lung injury. The...
- The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded Luminex Corporation a $1.2 million firm-fixed price purchase order to complete the final stages of obtaining FDA 510(k) clearance for its proprietary ARIES Flu A/B/RSV + SARS-CoV-2 diagnostic test. Luminex will perform necessary clinical evaluations and submit the 510(k) application to achieve long-term FDA clearance of the ARIES test, which the agency considers critical to its...
- The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response (ASPR), awarded Cepheid Inc. a definitive contract valued at $103.6 million on July 23, 2021, to establish a platform for diagnosis and surveillance of emerging pandemic threats. The contract, which extends through December 31, 2029, was awarded without a set-aside designation and operates under a cost-plus-no-fee pricing structure. The award originated from a Broad Agency...
- This $34,714,763.00 cost-plus-fixed-fee contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Detect Inc. to advance the development of a second-generation, multi-analyte molecular SARS-CoV-2 and influenza A/B test that has a reduced time to result and increased sensitivity for use at home or in a point-of-care setting. The contract is not set aside. The award references a Broad Agency Announcement (BAA) issued by the Biomedical Advanced Research...
Arete Biosciences, LLC was awarded a $745,000 firm fixed price definitive contract by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to develop an ultra-sensitive and cost-effective home-based disposable molecular platform for SARS-CoV-2 testing. The contract is being performed in Chicago, Illinois over a period of one year from June 2022 through August 2023. The award is responsive to Special Instructions 019 under the HHS ASPR Easy Broad Agency Announcement BAA-20-100-SOL-0002, which sought host-directed therapeutic candidates to aid long-term outcomes from lung injury through Area of Interest 12. Arete Biosciences will pursue safety review of candidates through Phase I and share resulting data and commercialization plans with the agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00006 | Other Administrative Action | $0 | 8/24/23 | |
| P00005 | Supplemental Agreement for work within scope | $0 | 6/22/23 | |
| P00004 | Supplemental Agreement for work within scope | $0 | 3/8/23 | |
| P00003 | Other Administrative Action | $0 | 12/15/22 | |
| P00002 | Supplemental Agreement for work within scope | $0 | 8/30/22 |